EUVIMEDEUVIMED entdecken
Crossref

The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma

Chengxiao Yu, Yuchen Tang, Maojie Liu, Xin Xu, Xinyuan Ge, Hongxia Ma, Guangfu Jin, Hongbing Shen, Ci Song iD, Zhibin Hu

Journal of Gastroenterology · 2024

DOI: 10.1007/s00535-024-02144-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Chengxiao Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Genome-Wide Association Study. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Funding Program for Excellent Postdoctoral Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent genome-wide association studies (GWASs) in liver diseases have generated some polygenic risk scores (PRSs), but their predictive effectiveness on hepatocellular carcinoma (HCC) risk assessment remains unclear. METHODS: Here, we constructed a novel combined polygenic risk score and evaluated its increment to the well-established risk model. We used 15 HCC-associated genetic loci from two PRSs and FinnGen GWAS data to calculate a PRS-combined score and to fit the related PRS model in the UK Biobank cohort (N = 436,162). The PRS-combined score was further assessed for risk stratification for HCC integrating with the recommended clinical risk scores. RESULTS: The PRS-combined model achieved a better AUC (0.657) than that of PRS-HFC (0.637) and PRS-cirrhosis (0.645). The top 20% of the PRS-combined distribution had a 3.25 increased risk of HCC vs. the middle decile (45-55%). At the population level, the addition of PRS-combined to the CLivD score significantly increased the C-statistic (from 0.716 to 0.746) and provided a remarkable improvement in reclassification (NRI = 0.088) at the 10-year risk threshold of 0.2%. In clinic, additional assessment of PRS-combined would reclassify 34,647 intermediate-risk participants as high genetic risk, corresponding to an increase of 63.92% (62/97) of the HCC events classified at high risk using the Fibrosis-4 alone. CONCLUSIONS: The PRS may enhance HCC risk prediction effectiveness in the general population and refine risk stratification of the conventional clinical indicator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsGenome-Wide Association StudyHumansMaleFemaleMiddle AgedRisk AssessmentAgedGenetic Predisposition to DiseaseMultifactorial InheritanceRisk FactorsAdultPredictive Value of TestsCohort StudiesPolymorphism, Single NucleotideGenetic Risk Score

Stichwörter der Autor:innen

Cohort studyHCCHCC screeningPRSPredictive model

Autor:innen und Institutionen

  • Health Management Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People's Republic of China.
  • Department of Health Management, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
  • Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
  • Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
  • Research Unit of Prospective Cohort of Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, 100142, People's Republic of China.
  • Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China. songci@njmu.edu.cn.

ORCID-Profile: Ci Song

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • Science and Technology Young Scientific and Technological Talents Project of Jiangsu Province
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Jiangsu Higher Education Institutions
  • Chinese Academy of Medical Sciences

Zitieren

APA

Yu, C., Tang, Y., Liu, M., Xu, X., Ge, X., Ma, H., Jin, G., Shen, H., Song, C., & Hu, Z. (2024). The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02144-5

Vancouver

Yu C, Tang Y, Liu M, Xu X, Ge X, Ma H, et al. The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02144-5

BibTeX
@article{Yu2024,
  author = {Yu, Chengxiao and Tang, Yuchen and Liu, Maojie and Xu, Xin and Ge, Xinyuan and Ma, Hongxia and Jin, Guangfu and Shen, Hongbing and Song, Ci and Hu, Zhibin},
  title = {The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma},
  journal = {Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s00535-024-02144-5}
}
Kostenlos starten →